Acarbose (Prandase) is now approved for use in COMBINATION with a sulfonylurea

    Acarbose (Prandase) is now approved for use in combination with a sulfonylurea. It was originally approved as monotherapy.

    This combination makes sense.

    Each drug works in a different way to lower blood sugar. Together they have additive effects.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote